APA (7th ed.) Citation

Okino, K., Suzuki, H., Tomioka, H., Sanada, K., Kawai, K., Iwanami, A., & Inamoto, A. (2023). Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant. Human Psychopharmacology: Clinical & Experimental, 38(3), 1. https://doi.org/10.1002/hup.2868

Chicago Style (17th ed.) Citation

Okino, Kazumaro, Hirohisa Suzuki, Hiroi Tomioka, Kenji Sanada, Keita Kawai, Akira Iwanami, and Atsuko Inamoto. "Efficacy and Safety of Lemborexant as an Alternative Drug for Patients with Insomnia Taking Gamma‐aminobutyric Acid–benzodiazepine Receptor Agonists or Suvorexant." Human Psychopharmacology: Clinical & Experimental 38, no. 3 (2023): 1. https://doi.org/10.1002/hup.2868.

MLA (9th ed.) Citation

Okino, Kazumaro, et al. "Efficacy and Safety of Lemborexant as an Alternative Drug for Patients with Insomnia Taking Gamma‐aminobutyric Acid–benzodiazepine Receptor Agonists or Suvorexant." Human Psychopharmacology: Clinical & Experimental, vol. 38, no. 3, 2023, p. 1, https://doi.org/10.1002/hup.2868.